PR
PROCEPT BioRobotics
PRCT · NASDAQ
$22.76 +7.41% (+$1.57)
1M +4.84%
Market Cap $1.30B
P/E Ratio -
Div. Yield -
ROE 30.62%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 3.84x
P/B 3.81x
P/E N/A
Growth
100 /100
Growing Rev. growth 60.14%
Book val. growth 22.90%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 63.74%
FCF margin 37.34%
Net margin 32.54%
Quality
9 /100
Poor ROIC 27.42%
Asset turnover 0.70x
ROE 30.62%
Debt
69 /100
Low Debt/Equity 0.23x
Int. coverage -30.52x
Current ratio 6.55x
Stability
68 /100
Stable Beta 0.90x
Profitable years 0
Rev. volatility 22.39%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PRCT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Larry L. Wood
Employees
888
Headquarters
San Jose
Evenimente viitoare
03 NOV.
Earnings
Upcoming earnings report